ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 15,580
+420 (2.77%)
Dec 10, 2025, 3:30 PM KST
ENCell Company Description
ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea.
The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease It also provides contracting development and manufacturing services for biopharmaceutical products.
The company was founded in 2018 and is based in Seoul, South Korea.
ENCell Co., Ltd.
| Country | South Korea |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: 701, Youngdong Daero Seoul South Korea | |
| Phone | 82 2 6205 8050 |
| Website | encellinc.com |
Stock Details
| Ticker Symbol | 456070 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7456070002 |
| SIC Code | 8731 |